Lb Pharmaceuticals LBRX
NASDAQ LBRX
$37.28 -1.10 (-2.87%)
At close: Oct 1, 2026 · 4:00 PM EDT

Lb Pharmaceuticals (LBRX) Other Non-Current Assets (2024 - 2026)

Updated

Lb Pharmaceuticals (LBRX) posted Other Non-Current Assets of $782,000 for Q2 2026, up 0.8% from the prior quarter.

Analysis

Lb Pharmaceuticals (LBRX) Other Non-Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Lb Pharmaceuticals' Other Non-Current Assets came in at $770,000, up 54.6% from FY2024.

  • In prior years, Lb Pharmaceuticals' Other Non-Current Assets was $498,000 in FY2024.
  • According to Business Quant data, Other Non-Current Assets for the three prior quarters was $776,000 (Q1 2026), $770,000 (Q4 2025) and $512,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Lb Pharmaceuticals 1.10 Bn 1.10 Bn - 782,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 782,000.00
Mar 31, 2026 776,000.00
Dec 31, 2025 770,000.00
Sep 30, 2025 512,000.00
Dec 31, 2024 498,000.00
API Access

Lb Pharmaceuticals Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=LBRX&period=max&api_key=YOUR_API_KEY